PIA
SYRS

Piedmont Investment Advisors’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Piedmont Investment Advisors’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-43
Closed -$4K – 2369
2018
Q2 		$4K Buy
+43
New +$4K ﹤0.01% 2291